Sean O’bryan
Business & Management
Lysogene
France
Biography
Sean is responsible for providing global regulatory strategic leadership and for the creation and maintenance of quality systems assuring global compliance. Prior to joining Lysogene, he was the Director of Regulatory Affairs at bluebird bio leading efforts on the treatment of the rare disease CCALD through LVV gene therapy where he initiated and led the RA CMC group across all programs including CNS, hematology and oncology. Prior to this, he worked 8 years at Genzyme/Sanofi serving as a global regulatory lead for the Cell Therapy and Regenerative Medicine division
Research Interest
Regulatory Affairs, Quality Systems
